about
Impact of sleep and its disturbances on hypothalamo-pituitary-adrenal axis activityPsychomotor retardation in depression: biological underpinnings, measurement, and treatmentSerotonin-1A receptor imaging in recurrent depression: replication and literature reviewEndocannabinoid signaling in the etiology and treatment of major depressive illness.The diagnosis of depression in disorder.Increased waking salivary cortisol and depression risk in preschoolers: the role of maternal history of melancholic depression and early child temperament.The structure of late-life depressive symptoms across a 20-year span: a taxometric investigation.Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology.Deep brain stimulation of the human reward system for major depression--rationale, outcomes and outlook.Clinical patterns and treatment outcome in patients with melancholic, atypical and non-melancholic depressionsSelective serotonin reuptake inhibitor efficacy in severe and melancholic depression.The effect of pre- vs. post-reward attainment on EEG asymmetry in melancholic depression.[Review of the guidelines of the Brazilian Medical Association for the treatment of depression (Complete version)].Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression.Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome.Association between vitamin b12 levels and melancholic depressive symptoms: a Finnish population-based studyCatatonia: a syndrome appears, disappears, and is rediscovered.The impact of classification on psychopharmacology and biological psychiatry.Rumination in bipolar disorder: evidence for an unquiet mindEpilogue: Lessons from the CONVERGE study of major depressive disorder in China.The factor structure of lifetime depressive spectrum in patients with unipolar depression.Metabolomic biosignature differentiates melancholic depressive patients from healthy controls.A comparison of melancholic and nonmelancholic recurrent major depression in Han Chinese women.An evaluation of neuroplasticity and behavior after deep brain stimulation of the nucleus accumbens in an animal model of depressionDefining melancholia: the primacy of psychomotor disturbance.The facets of melancholia.Does dopamine dysfunction drive depression?Toward an objective characterization of an anhedonic phenotype: a signal-detection approach.HPA axis and sleep: identifying subtypes of major depression.Cannabinoid receptor genotype moderation of the effects of childhood physical abuse on anhedonia and depression.The possible role of the kynurenine pathway in adolescent depression with melancholic featuresAnticipatory reward deficits in melancholiaSerum brain-derived neurotrophic factor, vascular endothelial growth factor and leptin levels in patients with a diagnosis of severe major depressive disorder with melancholic features.Role of endocannabinoid signaling in anxiety and depression.Classification of mood disorders in DSM-V and DSM-VI.Association between gastrointestinal symptoms and affectivity in patients with bipolar disorder.Novelty-seeking behavior predicts vulnerability in a rodent model of depression.Melancholia in Latin American studies: a distinct mood disorder for the ICD-11.Neuromodulation for treatment resistant depression: state of the art and recommendations for clinical and scientific conduct.Descriptive diagnostic assessment of depression Categorical diagnosis, dimensional assessment, and instruments.
P2860
Q24613705-B76A92B3-A04A-419C-870C-6D67371566E9Q24629825-1EADD35A-F942-4AF8-9AA1-8BF129481F1DQ24657080-02EE24BE-1DB4-4476-BEF0-570B9BAC332EQ30687668-376C04AC-2465-4651-BE9B-CDF3C317B4C6Q33543074-0532D064-01D7-4999-B501-7E0E58648CBAQ33583528-3377901D-D530-4453-B6F1-944ABBCDA7BFQ33774213-06285A66-6904-4EA1-B8BC-6A7FA83AA99DQ33886704-97A023F5-903C-4596-8241-4BCCD4624ECBQ34403430-0173763C-928F-4E02-B8BE-5080DA3991CCQ34461077-80EE9827-5AAF-4851-9E37-8F62834186B1Q34479180-60C5ED66-D2F1-41E1-B82D-BA403D7AC6F4Q34570666-7A04B09F-16A6-4F6F-B02A-0663ABE6B553Q34609457-4D32EE37-EA61-4B0A-A396-77A77B7CA458Q34618440-54E9CDD3-A91E-4950-AB50-F3888DBEB71EQ34678771-FBBDD22B-D809-4E63-8AE7-5DFDD4BCB776Q34738700-9BD16518-0FC4-49C7-9BC4-062AB18E557AQ34995968-ACEE1150-90A8-418C-BF51-DED6836B7765Q35236189-183C1981-714A-4EDB-BCC4-63F239A8F469Q36061678-1B6254F7-B321-4435-A120-CFD13593AAE1Q36069674-D6234CCF-01B5-408A-BBC2-231C138F24AEQ36070297-246A995F-55C3-49E2-8626-F0B13BF8BD83Q36109672-DA46D14C-EC32-43CD-B3FE-0C4D26AF7661Q36195814-B49700BB-E258-4109-A523-E5CB09659F66Q36450098-43104631-13FC-4DDB-9A55-BC7D0CAE8FFEQ36728889-C0293DBA-C47B-4B72-B9AD-17AC691849DFQ36728895-275D2F10-7841-47D7-9F0C-59E95E1564B3Q36728907-E5A38C6B-ABFE-45AD-BAC1-687C2A98CE50Q36749689-2330607B-3027-4721-AB67-69189F84804FQ36939724-7584458D-66A4-44C8-A3BF-0E0B1ED54B0CQ36996416-2D6528F8-934C-4C90-A85C-536858F9BF30Q37012125-E8A4186C-D9FF-4C73-84E1-98E5E3DE56BCQ37047880-662FDDDD-E5EC-4E72-9DA6-6C56DD668501Q37079021-2DBF6FFD-C8EA-4453-8B93-F23C42A977B2Q37254797-99427EFE-5DAF-4386-9EB0-9496634F1DBDQ37262876-55A74E7B-E709-48D1-A68A-211D08CD90A2Q37338943-162E042A-4016-4758-8A7A-B1DC5B9CB6B8Q37586937-8525C6AD-2839-479D-95C2-5ACF25BA753EQ37918426-4BCDB2F1-E2F5-4924-86D0-CEAFD502EA64Q38145016-6A9589F2-124F-432C-A165-58D69560C753Q38777348-F92B00BE-2903-4315-9F54-829DEC0E58A8
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Melancholic symptom features and DSM-IV.
@en
type
label
Melancholic symptom features and DSM-IV.
@en
prefLabel
Melancholic symptom features and DSM-IV.
@en
P356
P1476
Melancholic symptom features and DSM-IV.
@en
P2093
Weissenburger JE
P304
P356
10.1176/AJP.151.4.489
P407
P577
1994-04-01T00:00:00Z